AKT1 and cancer: In addition, the therapeutic mechanisms of TM and TMQ were related to the activation of transcriptional misregulation in the cancer pathway, inhibition of the cholinergic synapse pathway, the AMPK signaling pathway and the PI3K/Akt/mTOR signaling pathway, and inhibition of tumor cell proliferation.